NCT03746184

Brief Summary

The treatment that patients with knee OA are offered varies largely. There is a need for more evidence-based individualized guidance to treatment choice for knee osteoarthritis. This study will register and evaluate the course and outcome of treatment in 5,000 patients with knee osteoarthritis. The understanding of knee OA treatment will advance in three ways: Firstly, by describing the different treatment pathways that are currently being used for knee OA. Secondly, by identifying wich individual factors that may impact the outcome of the treatment course. And finally, by conducting the economic burden related to different treatment modalities.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 23, 2018

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

November 13, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 19, 2018

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 27, 2023

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

October 2, 2024

Status Verified

October 1, 2024

Enrollment Period

4.5 years

First QC Date

November 13, 2018

Last Update Submit

October 1, 2024

Conditions

Keywords

precision medicinePatient-Specific Modeling

Outcome Measures

Primary Outcomes (2)

  • Patient Acceptable Symptom State (PASS)

    Patients answer yes/no to a PASS question asking whether they consider the current symptom state to be acceptable.

    2 years after inclusion

  • Treatment Failure

    Patients who answer "no" to the PASS question will also answer "yes/no" to a question about whether they consider the treatment received to have failed.

    2 years after inclusion

Secondary Outcomes (4)

  • Patient Acceptable Symptom State (PASS)

    6 months after inclusion

  • Treatment Failure

    6 months after inclusion

  • Minimal Important Change

    6 months and 2 years after inclusion

  • Oxford Knee Score (OKS), range from 0 (worst) to 48 (best)

    6 months and 2 years after inclusion

Study Arms (1)

Knee osteoarthritis

Treatment course

Other: Treatment course

Interventions

Pursued treatment for knee OA, including type of health care provider, time period of treatment course, and types of treatments received, will be recorded via the patient-reported questionnaire.

Knee osteoarthritis

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients with primary referrals to one of two public hospitals orthopedic department's outpatient clinics due to knee osteoarthritis are consecutively invited to participate. The two hospitals cover the larger part of Zealand in Denmark.

You may qualify if:

  • primary referrals to one of two orthopedic department's outpatient clinics due to knee osteoarthritis

You may not qualify if:

  • previous total or unicompartmental knee replacement
  • osteotomy around the study knee
  • unable to read or write Danish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Orthopaedic Surgery, Copenhagen University Hospital Hvidovre

Hvidovre, 2650, Denmark

Location

Related Publications (2)

  • Bruhn SM, Skou ST, Harris LK, Bandholm T, Moller A, Schroder HM, Troelsen A, Ingelsrud LH. Usage of guideline-adherent core treatments for knee osteoarthritis before and after consulting an orthopaedic surgeon: A prospective cohort study. Osteoarthr Cartil Open. 2023 Sep 28;5(4):100411. doi: 10.1016/j.ocarto.2023.100411. eCollection 2023 Dec.

  • Bruhn SM, Ingelsrud LH, Bandholm T, Skou ST, Schroder HM, Reventlow S, Moller A, Kjellberg J, Kallemose T, Troelsen A. Disentangling treatment pathways for knee osteoarthritis: a study protocol for the TREATright study including a prospective cohort study, a qualitative study and a cost-effectiveness study. BMJ Open. 2021 Jul 7;11(7):e048411. doi: 10.1136/bmjopen-2020-048411.

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Anders Troelsen, Professor

    Copenhagen University Hospital, Hvidovre

    STUDY CHAIR
  • Lina H Ingelsrud, PhD

    Copenhagen University Hospital, Hvidovre

    STUDY CHAIR
  • Henrik M Schroeder, Asst. Prof.

    Næstved Sygehus, Denmark

    STUDY CHAIR
  • Søren T Skou, Assoc. Prof.

    Næstved-Slagelse-Ringsted Hospitals AND University of Southern Denmark

    STUDY CHAIR
  • Thomas Bandholm, Professor

    University of Copenhagen AND Copenhagen University Hospital Hvidovre, Denmark

    STUDY CHAIR
  • Jakob Kjellberg, Professor

    VIVE - The Danish Centre of Applied Social Science, Denmark

    STUDY CHAIR
  • Susanne Reventlow, Professor

    University of Copenhagen

    STUDY CHAIR
  • Anne Møller, Asst. Prof.

    University of Copenhagen

    STUDY CHAIR
  • Simon M Bruhn, M.Sc.

    Copenhagen University Hospital, Hvidovre

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, consultant, dr.med., PhD

Study Record Dates

First Submitted

November 13, 2018

First Posted

November 19, 2018

Study Start

October 23, 2018

Primary Completion

April 27, 2023

Study Completion

July 31, 2025

Last Updated

October 2, 2024

Record last verified: 2024-10

Locations